New GnRH Antagonist Shows Promise for LUTS
ANAHEIM, Calif.—Ozarelix, a GnRH antagonist given intramuscularly, is well tolerated and has significant and clinically meaningful efficacy in the treatment of lower urinary tract symptoms (LUTS) secondary to BPH, a study shows.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.